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Abstract. We estimated the seroprevalence and determined the frequency of acute infections with Neorickettsia
sennetsu, spotted fever group rickettsiae, Rickettsia typhi, and Orientia tsutsugamushi among 2,225 febrile patients
presenting to community hospitals in three rural Thailand provinces during 2002–2005. The seroprevalence was 0.2%
for sennetsu neorickettsiosis (SN), 0.8% for spotted fever group (SFG) rickettsiae, 4.2% for murine typhus (MT), and
4.2% for scrub typhus (ST). The frequency of acute infections was 0.1% for SN, 0.6% for SFG, 2.2% for MT, and 1.5%
for ST. Additional studies to confirm the distribution of these pathogens and to identify animal reservoirs and transmis-
sion cycles are needed to understand the risk of infection.
INTRODUCTION
Rickettsioses are infectious diseases caused by obligate
intracellular bacteria of the order Rickettsiales. The three
groups of diseases include 1) diseases due to bacteria of the
genus Rickettsia, including the spotted fever group (SFG)
and the typhus group; 2) scrub typhus (ST) due to Orientia
tsutsugamushi; and 3) ehrlichioses and anaplasmosis due to
bacteria within the family Anaplasmataceae.1 In southeast
Asia, rickettsial diseases have been found to be the second
most commonly reported cause of non-malarial febrile illness
after dengue infection.2 SFG rickettsioses are transmitted by
arthropod vectors, including ticks, fleas, and mites.1,3,4 Clini-
cal presentations can range from mild to life threatening,
varying by species and region, with case fatality rates as high
as 85%.5 SFG Rickettsia were initially found in ticks col-
lected from rats (Rattus rattus)6 in one province in Thailand
and identified as R. honei.6 The first three cases of serologically
confirmed SFG cases in humans were detected from patients
in Chiang Mai Province, Thailand.7 Subsequent reports
identified 11 cases of SFG rickettsioses. Two cases from
Chiang Rai Province were identified by polymerase chain
reaction (PCR) as R. felis.8 Eight cases from Kanchanaburi
Province were identified by immunofluorescent assay (IFA),
western blot, and cross-adsorption as one case R. felis, two
cases R. conorii, and five cases R. helvetica.9 The last case
from Bangkok had titer positive for R. honei.10
ST is transmitted to humans by the bite of larval
trombiculid mites, commonly known as chiggers.11 Murine
typhus (MT) is caused by R. typhi, which is present in rats
and mice and is known to be transmitted to humans by rat
fleas.12 ST and MT are important causes of febrile illness in
southeast Asia.13 The initial clinical characteristics of ST and
MT can vary and include fever, cough, headache, nausea,
vomiting, hepatosplenomegaly, rash, and gastrointestinal com-
plaints.14–17 MT generally can cause moderate to severe ill-
ness; case fatality rates ranging from 1% to 4%.16 On the
contrary, without proper treatment, patients with ST can
develop severe complications with case fatality rates as high
as 25%.18
Sennetsu neorickettsiosis (SN), caused by Neorickettsia
sennetsu (formerly Rickettsia sennetsu or Ehrlichia sennetsu),
was first described in Japan in 1954.19 The only published
report in Thailand found that 30 (3.7%) of 812 febrile
patients had positive antibody titers to N. sennetsu.20 A
recent study in Laos identified and confirmed N. sennetsu
in four (0.2%) of 1,637 febrile patients by PCR.21 Clinical
characteristics of SN include fever, chills, myalgia, headache,
hepatosplenomegaly, weakness, anorexia, lymphadenopathy,
and mononucleosis.11,20 Transmission is believed to occur
through consumption of raw fish (Anabas testudineus) con-
taminated with infected trematodes.20
Although several studies investigated the contribution of
ST and MT to acute febrile illness in Thailand, large studies
describing the seroprevalence and clinical characteristics of
SFG and SN are limited. Clinical diagnosis and laboratory
confirmation of rickettsial diseases can be challenging due
to cross-reactivity or unavailability or cost of the diagnostic
antigens, especially for SFG and SN, which may lead to
under-recognition of these pathogens. We assessed the sero-
prevalence as a measure of past infection in the population
and frequency of acute infection of SN, SFG, MT, and ST
among patients with acute febrile illness in Thailand.
MATERIALS AND METHODS
Setting. We tested stored specimens from a prospective
study of undifferentiated acute febrile illness conducted from
2002 to 2005. Enrollment occurred in two community hospi-
tals each in Chiang Rai (northern Thailand) during 2002–
2005, Khon Kaen (northeastern Thailand) during 2002–2004,
and Nakhon Phanom (northeastern Thailand) during 2004–
2005 (Figure 1). These facilities ranged from 60 to 90 beds
and served as the first point of care for patients requiring
hospital evaluation.
Study population. Research staff enrolled patients aged
≥ 7 years presenting to inpatient and outpatient departments
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with a history of fever for less than 2 weeks and a documented
temperature > 38°C at the time of evaluation. Patients were
excluded if they had an apparent focal infection (e.g., strepto-
coccal pharyngitis, meningitis, and urinary tract infection) or
a specific viral infection that could be diagnosed clinically
(e.g., mumps, croup, varicella, parvovirus, measles, and rubella),
had received an immunization in the preceding 48 hours, had
received blood products in the previous 6 months, or required
immediate transfer to a larger regional hospital.
Data and specimen collection. Research nurses performed
physical examinations and conducted interviews to collect
demographic and exposure information using standard ques-
tionnaires. Potential exposures included animal or arthropod
contact and outdoor activities during the 2 weeks before ill-
ness. Research nurses collected blood at enrollment and at
the convalescent visit 3–5 weeks later. Serum aliquots were
stored at −20°C before being transported on dry ice to the
Centers for Disease Control and Prevention (CDC) labora-
tory in Bangkok. Sera were stored at −70°C until tested.
Laboratory testing and interpretation. Frozen sera were
sent on dry ice to the French National Reference Center for
Rickettsiosis in 2013 where immunofluorescent assays (IFA)
were performed to detect anti-rickettsial antibodies as previ-
ously described.9 Each serum was tested for antibodies to a
panel of six antigens including N. sennetsu, R. honei, R. felis,
R. typhi, andO. tsutsugamushi (Gilliam and Kawasaki strains).
All sera were screened at a dilution of 1:50 and 1:100, and
those positive at 1:100 were tested by IFA to determine anti-
body titers. The IFA was considered positive if IgG titers
were ≥ 128 and/or IgM titers were ≥ 64 in either acute or
convalescent sera.9,22 For patients with serologic cross-reactions
with identical titers for different antigens, we considered that
the serology was positive for a given antigen if the antibody
titers were greater by two dilutions compared with other anti-
gens tested. Patients seropositive for more than one antigen at
identical titers were reported as positive for both antigens;
when titers to one antigen were greater by 2 dilutions, serol-
ogy was considered positive for the antigen with higher
titers. A seroconversion including a rise in IgG or IgM anti-
body titers between acute and convalescent sera was consid-
ered as a serologically confirmed acute infection.
Statistical analysis. Data were double entered and vali-
dated using Epi Info version 6.04 (CDC, Atlanta, GA) and
analyzed using SPSS version 20.0 (SPSS Inc., Chicago,
IL). Dichotomous variables were compared by χ2 or
Fisher’s exact test. Mann–Whitney U test was used to com-
pare the distribution across groups. Multivariate analysis was
performed for variables associated with each pathogen at a
P value < 0.1 in univariate analysis. Results are presented
as adjusted odds ratios (aORs) and 95% confidence inter-
vals (CIs). A P value < 0.05 was considered significant in
all calculations.
Ethical considerations. Research nurses obtained written
informed consent from all participants ≥ 18 years of age
and from the guardians of participants aged 7–17 years.
Verbal assent was given by participants < 18 years of
FIGURE 1. Location of study sites: two hospitals each in Chiang Rai, Khon Kaen, and Nakhon Phanom provinces, Thailand, 2002–2005.
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age. The protocol was approved by an institutional review
board of the U.S. Centers for Disease Control and Preven-
tion and the Ethical Review Committee, Ministry of Public
Health, Thailand.
RESULTS
During February 2002 to June 2005, we enrolled 2,446
(36%) of 6,830 eligible febrile patients, of which 63% were
outpatients. The main reason for non-enrollment was refusal
by the patient or guardian (59%). Of the participants, 60%
were male, lived largely in rural areas (61%), and had a
median age of 23 years (range = 7–89 years); 41% were stu-
dents. Of the 2,446 participants, 1,105 were enrolled from
hospitals in the northern region and 1,341 from the north-
eastern region. Ninety-one percent (2,225) of patients had
acute and convalescent sera available for testing. All patients
were tested for SFG and MT, while 1,603 (72%) patients
were tested for SN and ST. Compared with those without
serum available for SN and ST testing, participants with testing
had a similar male sex distribution (52% versus 55%, P = 0.08)
but were slightly younger (median age 25 [range 7–89] versus
31 [7–84 years], P < 0.01). Of 2,225 patients, 164 (7.4%) had
evidence of prior infection with one or more of SFG, MT,
SN, or ST (Figure 2) and 65 (2.9%) had evidence of acute
infection with at least one pathogen (Figure 3).
Sennetsu neorickettsiosis. Seroprevalence. Of 1,603 patients
tested, four (0.2%) had a positive antibody titer to SN in
acute (N = 2) or convalescent (N = 2) serum, two (0.1%)
had a positive titer to SN alone, and two (0.1%) had positive
titers to SN and ST (Figure 2). All four patients were from
northern Thailand hospitals.
Acute infection. Acute SN infection was confirmed in two
(0.1%) febrile patients. Both patients tested negative for
other rickettsial pathogens (Table 1). They were enrolled
from the same hospital in northern Thailand in June and
July 2002: Patient 1, a 58-year-old man, vital signs at hospital
presentation were body temperature 38.1°C, respiratory rate
22 breaths/minute, pulse rate 96/minute, and blood pressure
130/80 mmHg. Patient 2, a 59-year-old woman, vital signs at
hospital presentation were body temperature at hospital pre-
sentation 40.1°C, respiratory rate 20 breaths/minute, pulse
rate 88/minute, and blood pressure 100/50 mmHg (Table 1).
Spotted fever group. Seroprevalence. Of 2,225 patients
tested, 18 (0.8%) had a positive antibody titer to SFG in
acute (N = 8) or convalescent (N = 10) sera, five (0.2%)
patients had a positive titer to SFG alone, and 13 (0.6%)
had a positive titer to ≥ 1 additional rickettsial pathogen
(12 positive for MT and one positive for ST). Of the five cases
with positive titers to SFG alone, two were positive for
R. felis, one positive for R. honei, and two had positive titers
to both species. These five patients had a median age of 45
(range = 14–54) years; three were male and three were from
a northeastern province.
Acute infection. SFG acute infection was confirmed in nine
of 1,603 (0.6%) patients. One (11%) was infected with SFG
alone and eight (89%) had serologic evidence of acute infec-
tion with ≥ 1 additional pathogen based on a rise in antibody
titers (six with MT, one with ST, and one with both MT and
ST). The patients with evidence of acute infection to SFG
alone included a 45-year-old man from northern Thailand
presenting with myalgia, arthralgia, headache, cough, chest
pain, abdominal pain, photophobia, and vomiting. Vital signs
on admission were body temperature 40.2°C, respiratory
rate 28/minute, pulse rate 100/minute, and blood pressure
140/80 mmHg. He reported having contact with animals,
including cats and dogs, and being bitten by insects. He had
acute IgG/IgM titers to R. felis of 0/0 and convalescent titers
of 128/0. This patient was confirmed of having an acute infec-
tion with R. felis as detected by PCR.8
Murine typhus. Seroprevalence. Of 2,225 febrile patients
tested, 93 (4.2%) had a positive antibody titer to MT in
acute (N = 52) or convalescent (N = 41) sera; 77 (3.5%)
patients had a positive titer to MT alone and 16 (0.7%) had
positive titers to ≥ 1 additional pathogen (12 positive for
SFG and four positive for ST).
FIGURE 2. Febrile patients with positive antibody titers in acute or convalescent serum (IgG ≥ 128 or IgM ≥ 64) to spotted fever group
(SFG), murine typhus (MT), scrub typhus (ST), and sennetsu neorickettsiosis (SN) in the north and northeastern Thailand, 2002–2005.
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Acute infection. Acute MT infection was confirmed in 35
of 1,603 (2.2%) patients. Of 35 patients with MT infection,
28 (80%) were infected with MT alone and seven (20%) had
evidence of infection with ≥ 1 additional pathogen based on
a rise in antibody titers (six with SFG, one with SFG and
ST). Patients with MT infection alone (N = 28) were more
likely than other febrile patients (N = 1,451) to have elevated
alanine aminotransaminase (56% versus 27%, P < 0.01) and
aspartate aminotransferase (74% versus 49%, P = 0.01)
(Table 2). After controlling for age and sex, MT infection
remained significantly associated with rodent exposure within
the 2 weeks before illness (74% versus 49%, aOR = 2.9;
95% CI = 1.2–7.0).
Scrub typhus. Seroprevalence. Of 1,603 patients tested, 68
(4.2%) had a positive antibody titer to ST in acute (N = 48)
or convalescent (N = 20) sera, 61 (3.8%) patients had a posi-
tive titer to ST alone, and seven (0.4%) had positive titers
to ≥ 1 additional pathogen (four positive for MT, one posi-
tive for SFG, and two positive for SN).
Acute infection. ST acute infection was confirmed in 24
(1.5%) patients: 22 (92%) were infected with ST alone and
two (8.3%) were infected with ≥ 1 additional pathogen based
on a rise in antibody titers (one with SFG, one with MT and
SFG). Compared with other febrile patients (N = 1,451),
patients with ST infection alone (N = 22) more frequently
had rash (32% versus 11%, P < 0.01), elevated alanine
FIGURE 3. Febrile patients with serologically confirmed acute infection (a rise in IgG or IgM titers between acute and convalescent sera (i.e.,
seroconversion) with spotted fever group (SFG), murine typhus (MT), scrub typhus (ST), and sennetsu neorickettsiosis (SN) in the north and
northeastern Thailand, 2002–2005.
TABLE 1
Characteristics of febrile patients with serologically confirmed acute infection with Neorickettsia sennetsu, northern Thailand, 2002–2005
Characteristics Patient 1 Patient 2
Age (year) 58 59
Gender Male Female
Occupation Day laborer Messenger
Initial symptoms Fever 6 days, headache, fatigue, cough, chest pain,
myalgia, arthralgia, diarrhea, vomiting, and dyspepsia
Fever 5 days, fatigue, cough, chest pain, myalgia,
arthralgia, and gastrointestinal symptoms
Initial diagnosis Pharyngitis Enteric fever
Hospitalization No Yes
Leukocyte count, cells/mm3 5,200 7,200
Platelet count, cells/mm3 187,000 274,000
Hemoglobin, g/dL 13.4 13.1
Blood urea nitrogen, mg/dL 32 14.1
Creatinine, mg/dL 0.7 0.8
Alanine aminotransferase, IU/dL 24.6 12.0
Aspartate aminotransferase, IU/dL 23.8 0.5
Bilirubin, mg/dL 0.5 0.3
Alkaline phosphatase, IU/dL 198 45
History of animal contact within
2 weeks before illness onset
Mosquito bites Cats, dogs, rodents, and mosquito bites
History of eating raw fish No information No information
Acute titers, IgG/IgM 0/0 0/0
Convalescent titers, IgG/IgM 256/0 256/0
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aminotransaminase (73% versus 27%, P < 0.01), and elevated
aspartate aminotransferase (91% versus 49%, P < 0.01)
(Table 2). None had eschars detected by research nurses.
After controlling for age and sex, ST infection was signifi-
cantly associated with insect bites (aOR = 5.0; 95% CI =
2.1–11.7) and a history of cutting down trees, clearing land,
or gathering wood within the 2 weeks before illness (aOR =
2.7; 95% CI = 1.1–6.7). No ST patients received an initial
diagnosis of ST.
DISCUSSION
In a prospective study of over 2,000 patients with
undifferentiated febrile illness presenting to community
hospitals in northern and the northeastern Thailand, we
determined the frequency of acute infection with rickett-
sial, ST, and SN, which cumulatively accounted for 2.9%
of cases. The overall SFG, MT, and ST cases were lower
than that mentioned in the previous reports (5.9–18.6%) in
Thailand.23,24 However, those studies used different criteria
to interpret acute infection. If we applied the same criteria,
our acute infection cases will be up to 10%. Our description
of SN seroprevalence and acute SN infection adds to only
one previous report of SN seroprevalence in Thailand.20 We
found an SN seroprevalence of 0.2%, which was lower than
the previous study (3.7%) conducted in 2001–2003 among
812 febrile patients in northeastern and southern Thailand
provinces.20 In contrast to that study, no SN-positive patients
in our study were from the northeastern provinces.
SN was described in Japan more than 60 years ago, and it
is believed to be transmitted by the consumption of raw fish
contaminated with infected trematodes.20,21 Our study partic-
ipants were not asked about raw fish consumption, preclud-
ing assessment of this potential exposure. Pathogenic strains
of SN were also identified from the wood mouse and Norway
rat (Rattus norvegicus) in Japan.25 One of our patients with
acute SN infection reported recent contact with rodents,
similar to a recent study in Laos,21 but it is unknown whether
rodents have a role in disease transmission. The clinical char-
acteristics of SN patients in our study were similar to the pre-
vious study20,21 although neither had hepatosplenomegaly or
lymphadenopathy noted.
In Thailand, SFG Rickettsia were detected in ticks3,4,6 and
were associated with human disease.7–10 We found SFG sero-
prevalence (0.8%) lower than that from a previous study
(8.2–33%),26,27 but those studies used different assays (indi-
rect immunoperoxidase test and enzyme-linked immunosor-
bent assay). The clinical characteristics of SFG-infected patients
are generally nonspecific. Previously reported cases in Thailand
had fever, headache, injected conjunctivae, lymphadenopathy,
and rash.7,9 Patients in our study with acute SFG infection
alone had fever and headache, but had no lymphadenopathy
or rash. Almost three-quarters of patients in our study with
evidence of acute infection with both SFG and MT reported
rodent exposure within the 2 weeks before illness. If these
patients were truly coinfected, one could speculate that the
infections may have occurred through a common transmis-
sion pathway.
The seroprevalence of ST (4.2%) was similar to that of
a previous report among Thai soldiers from northeastern
Thailand (4.1%),28 but that study used a lower antibody
titer of ≥ 50 to define positivity. Using the same cutoff, sero-
prevalence in our study would be 5.6%. Clinical and labora-
tory characteristics that distinguished ST patients from other
febrile patients included a higher prevalence of rash, lymph-
adenopathy, thrombocytopenia, elevated liver enzymes, and
a lower prevalence of leukocytosis.15,29 The presence of an
eschar (the dark crusted ulcer at the site of chigger bites) is
often considered a hallmark of ST30 but based on clinician
reports and study nurse examinations; no patients with con-
firmed ST in our study had an eschar observed. Studies on
children ≤ 15 years with ST have found a range of eschar
TABLE 2




N = 28 (%) P value* N = 22 (%) P value* N = 1,451 (%)
Median age 34.5 0.03 24.5 0.9 28
Male sex 16 (57) 0.8 14 (67) 0.4 800 (55)
Headache 23 (82) 0.9 20 (91) 0.3 1,181 (81)
Cough 11 (39) 0.01 9 (41) 0.04 909 (63)
Myalgia 23 (82) 0.08 14 (64) 0.8 967 (67)
Arthralgia 9 (32) 0.6 9 (41) 0.7 528 (36)
Rash 4 (14) 0.6 7 (32) < 0.01 158 (11)
Lymphadenopathy 0 (0.0) 0.04 6 (27) 0.05 188 (13)
Hepatosplenomegaly 0 (0.0) 0.6 0 (0.0) 0.7 13 (0.9)
Hospitalization 15 (54) 0.07 9 (41) 0.7 536 (37)
White blood cell > 10,000 mm3 6 (21) 0.2 0 (0.0) < 0.01 469 (32)
Hemoglobin ≤ 12 g/dL 8 (29) 0.5 5 (23) 0.3 492 (34)
Platelet ≤ 149 mm3 5 (18) 0.8 8 (36) 0.05 285 (20)
Platelet ≤ 100 mm3 2 (7.1) 0.7 6 (27) < 0.01 81 (5.6)
Blood urea nitrogen ≥ 21 mg/dL 1 (3.7) 0.2 1 (4.5) 0.3 159 (11)
Creatinine ≥ 1.5 mg/dL 0 (0.0) 0.1 1 (4.5) 0.5 125 (8.6)
Alanine aminotransaminase ≥ 36 IU/dL 15 (56) < 0.01 16 (73) < 0.01 392 (27)
Aspartate aminotransferase ≥ 36 IU/dL 20 (74) 0. 01 20 (91) < 0.01 712 (49)
Bilirubin ≥ 1.3 mg/dL 4 (14) 0.2 2 (9.1) 0.9 118 (8.2)
Alkaline phosphatase ≥ 121 IU/dL 19 (68) 0.4 18 (82) 0.1 946 (65)
MT = murine typhus; ST = scrub typhus.
*P value for comparison between patients with corresponding rickettsial infection and other febrile patients with negative serology testing for any rickettsial species or sennetsu
neorickettsiosis (non-cases).
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prevalence from 7.2% (5/69) to 70% (21/30),15,31 while one
previous report noted a lack of eschar in 15 ST patients.32
Although a thorough examination for eschar is warranted
in patients with undifferentiated illness in ST-endemic areas,
disease cannot be ruled out by the lack of eschar. It is pos-
sible that our research nurses failed to detect eschars in
some patients.
MT has a worldwide distribution and is more prevalent in
southeast Asia.33 The seroprevalence of MT in our study
(4.2%) was lower than in a previous study (8.0%) in subur-
ban Bangkok,33 which used the indirect immunoperoxidase
assay and defined seropositivity as antibody titers > 50.
Using the same cutoff for positivity in our study would have
given a seroprevalence of 6.3%. Elevated liver enzymes were
common among patients with MT, consistent with previous
reports. Previous reports of MT cases also described frequent
anemia, thrombocytopenia, and leukopenia22,34,35; in our study,
anemia occurred in 29%, but thrombocytopenia in 7.1% and
leucopenia in 10%. We found that rodent exposure was inde-
pendently associated with MT, consistent with the fact that
rat fleas are known vectors.36
The nonspecific clinical presentation of rickettsioses may
lead to treatment delay if clinicians are not aware of the fre-
quency of disease. We found that none of SFG cases and
only one of 65 Rickettsia cases overall received a correspond-
ing clinical diagnosis. SFG, ST, or MT would not respond to
empiric treatment and needed to be treated with doxycy-
cline.29 Underdiagnosis can also delay appropriate antimicro-
bial therapy, which has been associated with poor patient
outcomes.18 The low percentage of patients with the correct
diagnosis results at least partially from the lack of valid diag-
nostic tests that can be performed in a community hospital
laboratory. A laboratory test that could be performed at the
facility level could greatly improve diagnosis and treatment
of febrile illness in Thailand.
Our study had several limitations. We enrolled only
patients seeking care in community hospitals, patients requir-
ing immediate transfer to a larger regional hospital were not
enrolled, and only 36% of eligible febrile patients partici-
pated, potentially limiting the generalizability of our find-
ings. The small number of serologically confirmed SFG and
SN cases limited the ability to assess clinical characteristics
and risk factors for these diseases. Although serology testing
is the standard for diagnosing rickettsial diseases and IFA is
generally the serological method of choice, serologic assays
are known to cross-react, especially assays for SFG with
assays for other rickettsial species.9,37 IFA results suggesting
coinfection with > 1 rickettsiosis should be interpreted in
light of this known cross-reactivity. Although direct detection
methods, such as PCR, were not used, we did use conserva-
tive serologic cutoffs to define seropositivity. Western blot
and cross-adsorption assays are recommended to be used to
distinguish Rickettsia species,1 but we lacked sufficient sera
for testing.
Our findings on MT and ST place renewed importance on
measures to prevent these diseases. Clinicians should main-
tain a level of suspicion for these important zoonotic diseases
and consider appropriate antibiotic therapy (e.g., doxycy-
cline) for patients with clinically consistent illnesses without
delay or waiting for laboratory diagnostic results. Additional
investigations are warranted to understand the epidemiol-
ogy of SFG and SN in Thailand, including animal reser-
voirs and transmission cycles. Laboratory capacity should be
strengthened to support diagnosis of rickettsial diseases to
refine prevalence estimates and improve data to inform con-
trol strategies.
SUMMARY
This study determined the frequency of acute infection
with SN, SFG and typhus group rickettsioses, as well as the
seroprevalence of these pathogens among febrile patients
in Thailand.
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